Cancer risk of heterozygotes with the NBN founder mutation.

MLA

Seemanová, Eva, et al. “Cancer Risk of Heterozygotes with the NBN Founder Mutation.” Journal of the National Cancer Institute, vol. 99, no. 24, Dec. 2007, pp. 1875–80. EBSCOhost, https://doi.org/10.1093/jnci/djm251.

APA

Seemanová, E., Jarolim, P., Seeman, P., Varon, R., Digweed, M., Swift, M., & Sperling, K. (2007). Cancer risk of heterozygotes with the NBN founder mutation. Journal of the National Cancer Institute, 99(24), 1875–1880. https://doi.org/10.1093/jnci/djm251

Chicago

Seemanová, Eva, Petr Jarolim, Pavel Seeman, Raymonda Varon, Martin Digweed, Michael Swift, and Karl Sperling. 2007. “Cancer Risk of Heterozygotes with the NBN Founder Mutation.” Journal of the National Cancer Institute 99 (24): 1875–80. doi:10.1093/jnci/djm251.